Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
24.63
+0.01 (0.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems.

In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions.

The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.

Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.

The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical, Inc.
Avanos Medical logo
Country United States
Founded 2014
Industry Medical Devices
Sector Healthcare
Employees 2,287
CEO David Pacitti

Contact Details

Address:
5405 Windward Parkway, Suite 100 South
Alpharetta, Georgia 30004
United States
Phone 844 428 2667
Website avanos.com

Stock Details

Ticker Symbol AVNS
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001606498
CUSIP Number 05350V106
ISIN Number US05350V1061
Employer ID 46-4987888
SIC Code 3842

Key Executives

Name Position
David C. Pacitti M.B.A. Chief Executive Officer and Director
Scott Michael Galovan Senior Vice President and Chief Financial Officer
Sigfrido Delgado Senior Vice President of Operations
Jason M. Pickett Vice President of Corporate Finance and Treasurer
John Joseph Hurley Principal Accounting Officer and Controller
Siobhan Smyth Vice President and Chief Information Officer
Jonathan Turner Vice President and Chief Ethics and Compliance Officer
John S. Fischer Esq. Vice President, Head of Legal and Secretary
Katrine Kubis Vice President of Corporate Communications and Community Relations
Jamie Handler Vice President of Global Marketing

Latest SEC Filings

Date Type Title
Apr 23, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 14, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 14, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 14, 2026 8-K Current Report
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 12, 2026 ARS Filing
Mar 12, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 12, 2026 8-K Current Report
Mar 12, 2026 DEF 14A Other definitive proxy statements
Feb 26, 2026 8-K Current Report